Deinove (Paris), a biotech start-up company developing processes for biofuels and biochemcials, has unveiled plans to undertake an initial public offering (IPO) in a bid to raise around €12 million ($16.3 million) in fresh equity. The company will make its offering on the Alternext market of NYSE Euronext in Paris. Deinove has set a guide price of between € 7.50 and € 9.16/share. The share offer is set to close on April 20, 2010. Deinove designs and develops breakthrough technologies based on Deinococcus bacteria. Processes the company is...
Already an IHS Chemical Week member? Login here
Forgot your user ID or password? Click here to have it sent to you.
Click here for 6 months access to the lates news, data and statistics on sustainability. PLUS all the news and analysis from the Chemical Week editorial team updated everyday on IHS Chemical Week